These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 1283006

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Chemotherapy for Hodgkin's disease.
    Ekert H.
    N Engl J Med; 2003 Sep 18; 349(12):1186-7; author reply 1186-7. PubMed ID: 13679536
    [No Abstract] [Full Text] [Related]

  • 3. [Laparotomy with splenectomy in the evaluation of the results of cytostatic treatment of patients with advanced Hodgkin's disease].
    Płuzańska A, Berner J, Kowalczyński M, Dowgier-Witczak I, Chmielowska E, Woźniak L.
    Pol Arch Med Wewn; 1986 May 18; 75(5):344-50. PubMed ID: 2431397
    [No Abstract] [Full Text] [Related]

  • 4. Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group.
    Pfreundschuh MG, Schoppe WD, Fuchs R, Pflüger KH, Loeffler M, Diehl V.
    Cancer Treat Rep; 1987 Dec 18; 71(12):1203-7. PubMed ID: 2446751
    [Abstract] [Full Text] [Related]

  • 5. [Controversy regarding the treatment of Hodgkin's disease].
    Balwierz W, Armata J.
    Pol Tyg Lek; 1989 Apr 03; 44(14):315-9. PubMed ID: 2482966
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of advanced stage Hodgkin lymphoma--it's all about risk-benefit.
    Phipps C, Lee YS, Hwang W.
    Br J Haematol; 2012 Oct 03; 159(1):113-5. PubMed ID: 22823109
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Controversial aspects in the current treatment of Hodgkin's disease].
    Vicente J.
    Rev Clin Esp; 1987 Feb 03; 180(3):158-64. PubMed ID: 2437622
    [No Abstract] [Full Text] [Related]

  • 9. [Rescue treatment in Hodgkin's disease].
    Zori Comba A, Koziner B.
    Sangre (Barc); 1987 Feb 03; 32(1):67-76. PubMed ID: 2438788
    [No Abstract] [Full Text] [Related]

  • 10. MOPP, ABVD, or both to treat Hodgkin's disease.
    Aisenberg AC.
    N Engl J Med; 1993 Apr 08; 328(14):1045; author reply 1045-6. PubMed ID: 7680765
    [No Abstract] [Full Text] [Related]

  • 11. Should MOPP-ABVD alone be standard for childhood Hodgkin's?
    Constine LS.
    J Clin Oncol; 1998 Mar 08; 16(3):1235. PubMed ID: 9508214
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
    Sieber M, Bredenfeld H, Josting A, Reineke T, Rueffer U, Koch T, Naumann R, Boissevain F, Koch P, Worst P, Soekler M, Eich H, Müller-Hermelink HK, Franklin J, Paulus U, Wolf J, Engert A, Diehl V, German Hodgkin's Lymphoma Study Group.
    J Clin Oncol; 2003 May 01; 21(9):1734-9. PubMed ID: 12721249
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.
    Diehl V, Franklin J, Pfreundschuh M, Lathan B, Paulus U, Hasenclever D, Tesch H, Herrmann R, Dörken B, Müller-Hermelink HK, Dühmke E, Loeffler M, German Hodgkin's Lymphoma Study Group.
    N Engl J Med; 2003 Jun 12; 348(24):2386-95. PubMed ID: 12802024
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of MOPP/MOPP +/- RT vs. MOPp/ABVD +/- RT in poor prognosis Hodgkin's disease. Long-term results.
    Comella P, Abate G, Fiore M, Di Finizio G, Frezza P, Scoppa G, Anania C, Coucourde F, Zarrilli D.
    J Chemother; 1989 Jul 12; 1(4 Suppl):1254-6. PubMed ID: 16312855
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.